News & Articles

Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions

Explore high-sensitivity troponin, antibiotic stewardship, mass spec, and more innovations and tools shaping the future of clinical labs

Partnership seeks to improve patient outcomes and experiences through novel digital and diagnostic solutions

Study shows PacBio's HiFi long-read sequencing can identify genetic causes of rare diseases, potentially simplifying diagnostics

Critical study will evaluate clinical feasibility of multi-cancer detection screening tests and begin to determine how best to incorporate them into the standard of care

AI-powered solution to enhance diagnostic efficiency, streamline clinical trials, and improve patient outcomes across global pathology networks

This partnership is revolutionizing bladder cancer diagnostics with seamless access to non-invasive genomic testing and enhanced clinical efficiency

The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA

Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early

The latest solution to enable comprehensive genomic profiling of tumors was presented at the annual meeting of the Association of Molecular Pathology

A solution for infectious disease research, delivering rapid, flexible, and scalable pathogen detection

The strategic partnership combines cutting-edge molecular profiling technology with unparalleled biospecimen and tissue profiling services

New data presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA and RNA

Aims to streamline clinical lab workflows with integrated tissue enrichment and nucleic acid purification solutions

CancerKB 4.0 promises comprehensive, report-ready diagnostic, prognostic, and therapeutic insights for hematological cancers, streamlining workflows with curated data from NCCN, WHO, and more

New laboratory operating system revealed at the 2024 AMP Conference in Vancouver, Canada

New guidelines for SARS-CoV-2 genomic surveillance aim to standardize NGS practices

nRichDX to unveil advanced liquid biopsy solutions at AMP 2024, showcasing high-yield sample prep innovations to enhance sensitivity in oncology diagnostics

QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission

New social media channels will better serve the clinical community by making it even easier to stay up to date

Germline sequencing provides crucial insights into clonal hematopoiesis mutations with the potential to improve cancer patient outcomes and new oncology therapy development

Brand new event designed to bring together everyone working in the clinical laboratory science industry

Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice

Explore the modern point-of-care ecosystem and its impact on healthcare delivery

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization